Cargando…

Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders

Over the last few years, treatment principles have been changed towards more targeted therapy for many B-cell lymphoma subtypes and in chronic lymphocytic leukemia (CLL). Immunotherapeutic modalities, namely monoclonal antibodies (mAbs), bispecific antibodies (bsAbs), antibody-drug conjugates (ADCs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mihályová, Jana, Hradská, Katarína, Jelínek, Tomáš, Motais, Benjamin, Celichowski, Piotr, Hájek, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584080/
https://www.ncbi.nlm.nih.gov/pubmed/34768899
http://dx.doi.org/10.3390/ijms222111470